Mr. Murphy, If insurance companies are pushing back on prescriptions it may be premature for new DTC commercials. Better to have everything in place including your sales rep force and the insurance companies. My hope is that that if there is a chance BP will do a takeout of AMRN, AMRN might hold off on DTC until we are in the hands of BP and BP can then brand Vascepa under their own flag/label.